Assays

Product Focus- Assays/Controls

Dec. 23, 2024
Extend the power of HPV testing BD Onclarity HPV Assay offers extended genotyping to identify high-risk HPV types beyond 16, 18, and 45 and is approved for self-collection in ...
hero_0924
Video

CLSI’s Focused on Preparing Labs for Change

Sept. 11, 2024
Clinical and Laboratory Standards Institute (CLSI) CEO Barb Jones shares how the global nonprofit’s standards, training and educational offerings prepare labs to meet the...
Courtesy of QuidelOrtho
7600_front_transparent
ADLM 2024: DIASORIN
Video

Flexible Syndromic Solutions for Respiratory Diagnostics 

Aug. 30, 2024
Michelle Tabb and Giulia Amicarelli of Diasorin discuss the current challenges for respiratory testing and how customizable syndromic testing is contributing to diagnostic stewardship...
Courtesy of Bio-Rad
spiaplusproductimage2
Assays

Bio-Rad launches new Specialty Immunoassay Plus controls

Aug. 23, 2024
Next generation of independent specialty IA quality controls features procalcitonin in liquid format.
Photo 323621432 © Aumporn Charicha | Dreamstime.com
Assays

Diasorin receives FDA de-Novo grant for the Simplexa C. auris Direct assay on the LIAISON MDX instrument

July 19, 2024
Simplexa C. auris Direct is a is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument for the direct in vitro qualitative detection of Candida auris DNA...
By Africa Studio on Adobe Stock
Photo 47559398 © Mark Adams | Dreamstime.com
Courtesy of Roche
Assays

Roche granted FDA Breakthrough Device Designation for pTau217 blood test to support earlier Alzheimer's disease diagnosis

April 12, 2024
Roche and Lilly believe the test could play an important role in improving access to early and accurate Alzheimer’s diagnosis.